Artificial T-cell receptors.

Area of Science:

• Immunology
• Biotechnology
• Molecular Biology

Background:

• Artificial T-cell receptors (TCRs) are engineered molecules combining antigen-binding domains with signaling endodomains.
• Commonly, ectodomains are derived from antibody or TCR variable chains, while endodomains often utilize CD-zeta.
• CD-zeta signaling, while inducing IFN-γ release and cell killing, has limitations in transmitting full T-cell activation signals.

Purpose of the Study:

• To explore the design and application of artificial T-cell receptors for enhanced T-cell-based immunotherapies.
• To investigate methods for improving T-cell activation signals beyond traditional CD-zeta signaling.
• To highlight the potential of artificial TCRs in generating specific T cells efficiently for therapeutic purposes.

Main Methods:

• Constructing artificial T-cell receptors by linking antigen-recognizing ectodomains to signaling endodomains.
• Utilizing various ectodomain designs and exploring novel endodomain combinations for enhanced signaling.
• Employing gene transfer techniques to introduce artificial TCRs into T cells.

Main Results:

• Combinations of signaling molecule segments in endodomains facilitate more potent T-cell activation, including proliferation.
• Artificial TCRs enable the grafting of virtually any specificity onto T cells, bypassing laborious selection processes.
• Demonstrated efficacy against tumors in animal models and successful Phase I/II studies in HIV-infected individuals.

Conclusions:

• Artificial T-cell receptors represent a rapidly advancing technology with significant potential for adoptive immunotherapy.
• This approach allows for the generation of large numbers of antigen-specific T cells efficiently.
• Further development of artificial TCRs promises new therapeutic strategies for various diseases, including cancer and infectious diseases.